0001209191-18-057721.txt : 20181108
0001209191-18-057721.hdr.sgml : 20181108
20181108141806
ACCESSION NUMBER: 0001209191-18-057721
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20181106
FILED AS OF DATE: 20181108
DATE AS OF CHANGE: 20181108
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Szela Mary T
CENTRAL INDEX KEY: 0001410289
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37620
FILM NUMBER: 181169254
MAIL ADDRESS:
STREET 1: 10835 ROAD TO THE CURE
STREET 2: SUITE 205
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Kura Oncology, Inc.
CENTRAL INDEX KEY: 0001422143
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 611547851
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3033 SCIENCE PARK ROAD, SUITE 220
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: (858) 500-8800
MAIL ADDRESS:
STREET 1: 3033 SCIENCE PARK ROAD, SUITE 220
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
FORMER COMPANY:
FORMER CONFORMED NAME: ZETA ACQUISITION CORP III
DATE OF NAME CHANGE: 20071227
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-11-06
0
0001422143
Kura Oncology, Inc.
KURA
0001410289
Szela Mary T
C/O KURA ONCOLOGY, INC.
3033 SCIENCE PARK ROAD, SUITE 220
SAN DIEGO
CA
92121
1
0
0
0
Option to purchase common stock
11.55
2018-11-06
4
A
0
30000
0.00
A
2028-11-05
Common Stock
30000
30000
D
Option to purchase common stock
11.55
2018-11-06
4
A
0
7583
0.00
A
2028-11-05
Common Stock
7583
7583
D
This option vests in three equal annual installments commencing on the one year anniversary of the date of grant.
This option vests in full on the one year anniversary of the date of grant.
Annette North, Attorney-in-fact for Mary Szela
2018-11-08